SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-001174
Filing Date
2024-04-01
Accepted
2024-04-01 10:35:08
Documents
9
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 6-K zk2431218.htm 6-K 27188
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 9540
3 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 13598
4 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 192539
5 EXHIBIT 10.2 exhibit_10-2.htm EX-10.2 124568
6 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 14778
7 image00002.jpg GRAPHIC 390949
8 image00003.jpg GRAPHIC 12815
9 image00005.jpg GRAPHIC 436875
  Complete submission text file 0001178913-24-001174.txt   1541359
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 24806279
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)